Updates
Regular updates related to sourcing and the management of health products are available on this page.
-
07 April 2026
Opportunity for Evaluation of Finished Pharmaceutical Products Lenacapavir for Pre-Exposure Prophylaxis
-
-
-
-
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). This evaluation will focus particularly on Antit...
-
This new policy describes the main standards and requirements for Principal Recipients purchasing and deploying malaria vector control products through Global Fund resources.
-
16 April 2024
Post-market surveillance of insecticide-treated nets
-
-
To respond to the changing regulatory environment and enhance equitable access to quality assured health products, the Global Fund has updated its Quality Assurance Policy for Pharmaceuticals and Quality Assurance Policy for Medical Devices (includin...
-
The open Expert Review Panel for Diagnostic Products (ERPD) call for Expression of Interest (EOI) for HIV rapid diagnostic tests manufactured in Africa (GF/ERPD/Adhoc 24/08-2023) has been updated to expand the eligibility to include tests manufacture...
-
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).
-
19 October 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). -
-
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics.
-
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
-
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia... -
17 March 2022
Global Health Supply Chain Dialogue
The Global Fund is organizing a Global Health Supply Chain Dialogue from 29 to 31 March 2022 under the theme “Building Resilient Supply Chains for Effective Pandemic Preparedness”. -
Following an LFA verification of a Recipient’s procurement, the QA Team would like to bring to the attention of the procurement community that certain Personal Protective Equipment (PPE) products and medical devices, and related documents, prominentl...
-
The U.S. Food and Drug Administration (FDA) has recently published a safety communication on Pulse Oximeter Accuracy and Limitations.
-
02 December 2021
The Supply Chain Roadmap
Robust and resilient supply ecosystems are essential to support the fight against HIV, tuberculosis (TB) and malaria. COVID-19 has put enormous pressure on health systems worldwide, with a clear need to strengthen and accelerate the development of su...